Average Co-Inventor Count = 8.94
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (9 from 2,405 patents)
2. Schering Corporation (9 from 1,829 patents)
3. Pharmacopeia Inc. (2 from 101 patents)
4. Pharmacopeia Drug Discovery, Inc. (2 from 52 patents)
5. Msd R&d (China) Co., Ltd. (1 from 10 patents)
6. Schering Coporation (1 from 3 patents)
7. Msd R&d Co., Ltd. (0 patent)
19 patents:
1. 10646494 - Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases
2. 10138255 - Piperazine derivatives as HIV protease inhibitors
3. 9840478 - Piperazine derivatives as HIV protease inhibitors
4. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
5. 8609676 - 4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors
6. 8609635 - Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
7. 8586576 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
8. 8580782 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
9. 8318735 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
10. 8076479 - Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro-pyrazolo[1,5-a]pyrimidin-7-yl)-amino derivatives and intermediates
11. 7807683 - N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
12. 7605155 - Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
13. 7452902 - Imidazopyridines as cyclin dependent kinase inhibitors
14. 7342016 - Farnesyl protein transferase inhibitors as antitumor agents
15. 7196078 - Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors